Search Orphan Drug Designations and Approvals
-
Generic Name: | rociletinib |
---|---|
Date Designated: | 05/14/2013 |
Orphan Designation: | Treatment of non-small cell lung cancer and mutations in the epidermal growth factor receptor |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Clovis Oncology, Inc. 5500 Flatiron Parkway Suite 100 Boulder, Colorado 80301 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-